Search

everythinglearnresearchcommunity

for

Search:↓

Betamethasone is more effective for hair regrowth than latanoprost but has more side effects.

Nutrient antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

PRP therapy effectively treats alopecia areata and atrophic acne scars.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.

Microneedling with Triamcinolone acetonide is an effective, less invasive, and safe alternative to direct injections for treating alopecia areata.

Liquid nitrogen cryotherapy is an effective treatment for alopecia areata.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Artemis dysfunction might cause hair loss through telomere shortening.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Platelet-rich plasma (PRP) is a cheap and easy treatment for hair loss, but not suitable for everyone. It also helps in healing ulcers, rejuvenating skin, and improving hair transplants.

Mice lacking a key DNA methylation enzyme in skin cells have a lower chance of activating stem cells necessary for hair growth, leading to progressive hair loss.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Fluconazole can cause temporary hair loss, which stops after reducing or stopping the drug.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

The report suggests a possible link between hair loss and hidden scalp tumors but states more evidence is needed to confirm this.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.